Brazil Continuous Glucose Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Components (Durables and Sensors), By End-use (Homecare Settings, Hospitals, and Others), and Brazil Continuous Glucose Monitoring Market Insights, Industry Trend, Forecasts to 2033.

Brazil Continuous Glucose Monitoring Market Insights Forecasts to 2033

• The Brazil Continuous Glucose Monitoring Market Size Was Estimated at USD 267.31 Million in 2023.
• The Market is Growing at a CAGR of 12.71% from 2023 to 2033
• The Brazil Continuous Glucose Monitoring Market Size is Expected to Reach USD 884.49 Million by 2033

The Brazil Continuous Glucose Monitoring Market Size  is expected to reach USD 884.49 million by 2033, growing at a CAGR of 12.71% from 2023 to 2033.

Market Overview

The Brazilian market for continuous glucose monitoring (CGM) refers to the class of medical equipment and digital health solutions that measure diabetics' blood sugar levels in real-time.  A sensor that is placed under the skin, a transmitter that transmits data to a phone or receiver, and software that provides glucose trend analysis are all part of CGM systems. These systems help patients manage their blood sugar levels and reduce the need for traditional fingerstick testing by giving continuous feedback. The market offers a wide range of products, from standalone CGM units to hybrid systems that can be connected to insulin pumps to improve diabetes treatment and reduce complications. The rising incidence of diabetes in Brazil is one of the factors propelling the market's expansion.  The need for advanced glucose monitoring devices has increased due to the rise in type 1 and type 2 diabetes caused by lifestyle, urbanization, and heredity. Patients and doctors use CGM devices as a result of increased awareness of diabetes management and the benefits of real-time glucose monitoring.  Additionally, technological advancements like artificial intelligence, predictive modeling, and smartphone connectivity optimize the efficiency and practicality of CGM devices. Brazil's government programs, including the Ministry of Health's diabetes management initiatives, are driving market growth by increasing access to key diabetes technologies, reducing costs, and integrating digital health solutions.

Report Coverage

This research report categorizes the market for the Brazil continuous glucose monitoring market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing Brazil continuous glucose monitoring market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Brazil continuous glucose monitoring market. 

Driving Factors

The rising incidence of diabetes is driving the demand for cutting-edge glucose monitoring equipment, which in turn is driving the Brazil Continuous Glucose Monitoring (CGM) market. Active diabetes management encourages increased use of CGM devices to reduce the incidence of hypoglycemia and hyperglycemia complications as static glucose recording gives way to real-time blood sugar monitoring. The accuracy and usability of CGM are further enhanced by technological developments like smartphone connectivity, AI-powered analytics, and integration with insulin pumps. The market expansion is driven by increased patient and healthcare provider awareness, digital health solutions, and remote monitoring, leading to a rise in the use of CGM.

Restraining Factors

The market for CGM devices in Brazil faces challenges due to high costs, lack of reimbursement policies, limited training, regulatory barriers, and quality approvals. Increased government support and healthcare infrastructure development are needed to make CGM systems more accessible to Brazil's growing diabetic population.

Market Segmentation

The Brazil continuous glucose monitoring market share is classified into components and end-use.

• The sensors segment accounted for the largest share in 2023 and is expected to grow at a CAGR of 15.42% during the forecast period.

Based on the components, the Brazil continuous glucose monitoring market is divided into durables and sensors. Among these, the sensors segment accounted for the largest share in 2023 and is expected to grow at a CAGR of 15.42% during the forecast period. The expansion of the segment is anticipated to be fueled by technological developments that increase sensor accuracy throughout the projected period. In addition, sensors used in continuous glucose monitoring (CGM) systems are implanted into fat tissue beneath the skin.  These sensors use glucose oxidase, which turns glucose into hydrogen peroxidase and produces an electrical signal, to measure blood glucose levels.  Chemical layers give the longevity of the sensor.

• The homecare settings segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR during the projected timeframe.

Based on the end-use, the Brazil continuous glucose monitoring market is classified into homecare settings, hospitals, and others. Among these, the homecare settings segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR during the projected timeframe. This segment is growing due to these devices help patients take fewer doses of insulin and allow for constant blood glucose monitoring.  The demand for CGM devices is anticipated to increase in homecare settings due to the convenient and effective blood glucose monitoring they provide. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Brazil continuous glucose monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, business strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Ascensia
• Abbott
• Dexcom
• GlySens
• Medtronic
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In June 2024, in Brazil, MicroTech Medical introduced the AiDEX CGM system, which uses cutting-edge sensor technology to monitor real-time blood glucose levels.

Market Segment

This study forecasts revenue at Brazil, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Brazil continuous glucose monitoring market based on the below-mentioned segments:

Brazil Continuous Glucose Monitoring Market, By Components

• Durables
• Sensors

Brazil Continuous Glucose Monitoring Market, By End-use

• Homecare Settings
• Hospitals
• Others